These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8193380)
21. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750 [TBL] [Abstract][Full Text] [Related]
23. Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia. Fitchen JH; Gale RP; Cline MJ Transplantation; 1980 Mar; 29(3):223-6. PubMed ID: 6987787 [No Abstract] [Full Text] [Related]
24. Bone marrow transplantation for severe aplastic anemia in Japan. Kanamaru A; Nagai K Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812 [TBL] [Abstract][Full Text] [Related]
25. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia. Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856 [TBL] [Abstract][Full Text] [Related]
26. Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literature. Pedersen-Bjergaard J; Ernst P; Nissen NI Scand J Haematol; 1978 Jul; 21(1):14-8. PubMed ID: 358370 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353 [TBL] [Abstract][Full Text] [Related]
28. Successful bone marrow transplantation in sensitized recipients. Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine. Takpradit C; Prockop SE; Kernan NA; Scaradavou A; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F J Pediatr Hematol Oncol; 2018 May; 40(4):e220-e224. PubMed ID: 29432302 [TBL] [Abstract][Full Text] [Related]
30. Selection of patients for bone marrow transplantation in severe aplastic anemia. Camitta BM; Rappeport JM; Parkman R; Nathan DG Blood; 1975 Mar; 45(3):355-63. PubMed ID: 1090310 [TBL] [Abstract][Full Text] [Related]
31. Patients with aplastic anemia (AA) before or after treatment with anti-thymocyte globulin (ATG) may exhibit clonal hematopoiesis. van Kamp H; Landegent JE; Willemze R; Fibbe WE Bone Marrow Transplant; 1991; 7 Suppl 2():99. PubMed ID: 1678979 [No Abstract] [Full Text] [Related]
32. Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation. Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M Prog Clin Biol Res; 1984; 148():249-58. PubMed ID: 6379663 [No Abstract] [Full Text] [Related]
33. Long-term complete autologous reconstitution following cyclophosphamide and allogeneic marrow infusion in a case of severe aplastic anemia. Bussel A; Dumont J; Schenmetzler C; Seger J; Marcelli-Barge A; Hors J Nouv Rev Fr Hematol (1978); 1985; 27(1):15-8. PubMed ID: 3887328 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients]. Arranz R; Steegmann JL; Fernández-Garesse D; Figuera A; Vázquez L; Fernández-Rañada JM Rev Clin Esp; 1989 Feb; 184(3):121-4. PubMed ID: 2655043 [TBL] [Abstract][Full Text] [Related]
35. Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party. Samarasinghe S; Clesham K; Iacobelli S; Sbianchi G; Knol C; Hamladji RM; Socié G; Aljurf M; Koh M; Sengeloev H; Dalle JH; Robinson S; Van Lint MT; Halkes CJM; Beelen D; Mufti GJ; Snowden J; Blaise D; de Latour RP; Marsh J; Dufour C; Risitano AM; Am J Hematol; 2019 Jan; 94(1):80-86. PubMed ID: 30328134 [TBL] [Abstract][Full Text] [Related]
36. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody. Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661 [No Abstract] [Full Text] [Related]
37. High BPA in aplastic anemia, a possible indicator of immune pathogenesis. Nissen C; Speck B Haematol Blood Transfus; 1979; 24():103-9. PubMed ID: 540791 [No Abstract] [Full Text] [Related]
38. Bone marrow transplantation for severe aplastic anemia. A report of 9 cases. Marmont AM; Van Lint MT; Avanzi G; Reali G; Adami R; Soldá A; Strada P; Barbanti M; Mingari MC; Soro O; Grazi G; Pedullá D; Cerri R; Rossi E; Giordano D; Santini G; Carella A; Risso M; Vimercati R; Piaggio G; Raffo MR; Librace E; Vitale V; Bacigalupo A Acta Haematol; 1979; 62(3):121-7. PubMed ID: 43062 [TBL] [Abstract][Full Text] [Related]